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Abstract
Objective: To compare maternal and perinatal outcomes between vacuum extraction 
and second- stage cesarean delivery (SSCD).
Methods: The present observational cohort study was conducted among women with 
term vertex singleton pregnancies who underwent vacuum extraction or SSCD at 
Mulago National Referral Hospital, Kampala, Uganda, between November 25, 2014, 
and July 8, 2015. Severe maternal outcomes (mortality, uterine rupture, hysterectomy, 
re- laparotomy) and perinatal outcomes (mortality, trauma, low Apgar score, convul-
sions) were compared between initial delivery mode.
Results: Among 13 152 deliveries, 358 women who underwent vacuum extraction 
and 425 women who underwent SSCD were enrolled in the study. No maternal deaths 
occurred after vacuum extraction versus five deaths from complications of SSCD. 
Vacuum extraction was associated with less severe maternal outcomes compared 
with SSCD (3 [0.8%] vs 18 [4.2%]; adjusted odds ratio [aOR] 0.24, 95% confidence 
interval [CI] 0.07–0.84). Fetal death during the decision- to- delivery interval was also 
less common in the vacuum extraction group (3 [0.9%] vs 18 [4.4%]; aOR 0.24, 95% CI 
0.07–0.84); however, the perinatal mortality rate did not differ between the vacuum 
extraction and SSCD groups (29 [8.4%] vs 45 [11.0%], respectively; aOR 0.83, 95% CI 
0.49–1.41). One infant in each group exhibited neurodevelopmental anomalies at 
6 months.
Conclusion: Vacuum extraction had better maternal outcomes and equivalent perina-
tal outcomes compared with SSCD. These findings encourage re- introduction of 
 vacuum extraction.
K E Y W O R D S
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1  | INTRODUCTION
With 275 288 maternal deaths, 2.1 million stillbirths, and 2.0 million 
early neonatal deaths recorded worldwide in 2015, maternal and perina-
tal mortality are global health priorities.1,2 Most maternal and perinatal 
deaths occur in low- income and middle- income countries (LMICs).1,2
Vacuum extraction is an evidence- based intervention that is used to 
shorten the second stage of labor. Indications for this approach include 
fetal distress, prolonged second stage of labor, maternal exhaustion, or 
the need to avoid expulsive efforts among women with conditions such 
as heart failure or severe anemia.3,4 Although vacuum extraction can 
reduce maternal mortality from hemorrhage and sepsis—as well as peri-
natal mortality from birth asphyxia—use of this method has almost disap-
peared from obstetric practice in many LMICs.5–8 One study6 found that 
instrumental vaginal delivery was not used in almost half of 1728 Sub- 
Saharan African hospitals, with usage rates below 1% in the remaining 
centers. Reasons for this deficit include lack of functioning equipment, 
lack of trained personnel, staff perceptions regarding trauma to the 
fetus, and fear of mother- to- child transmission of HIV.6–8 Consequently, 
many women in LMICs undergo avoidable cesarean delivery.9
The use of cesarean delivery, especially when performed during 
the second stage of labor, increases the risks of hemorrhage and 
infection, which are two of the main drivers of global maternal mor-
tality.10–12 In addition, a scarred uterus is a risk factor for uterine rup-
ture and abnormally invasive placenta in subsequent pregnancies.13 
These risks are particularly high in low- resource settings, where many 
deliveries happen outside healthcare facilities; access to safe surgery 
and anesthesia cannot be taken for granted; blood for transfusion is in 
short supply; and fertility rates are high.14,15 Therefore, it is crucial that 
unnecessary cesarean delivery is avoided.16–18
Published literature regarding outcomes of vacuum extraction 
among LMICs is scarce. Most studies lack follow- up, and vac-
uum extraction was not compared with alternative management 
options.19–21 In 2012, vacuum extraction was reimplemented in the 
main tertiary hospital in Uganda (Mulago National Referral Hospital, 
Kampala). This initiative led to declines in intrapartum stillbirths and 
uterine ruptures of 24% and 26%, respectively.7
The use of vacuum extraction was hypothesized to reduce mater-
nal morbidity, perinatal morbidity, and the decision- to- delivery interval 
(DDI) when compared with second- stage cesarean delivery (SSCD).12 
The aim of the present study was to test this hypothesis among preg-
nant women attending Mulago National Referral Hospital.
2  | MATERIALS AND METHODS
The present prospective observational cohort study was conducted 
among women undergoing vacuum extraction or SSCD in the main labor 
ward of Mulago National Referral Hospital between November 25, 2014, 
and July 8, 2015. Women with a term singleton pregnancy in vertex pres-
entation who delivered by vacuum extraction or SSCD at the study center 
were included, as were those who developed a ruptured uterus while 
in the second stage of labor and waiting for the intervention. Women 
who experienced a ruptured uterus before the decision for intervention 
(vacuum extraction or SSCD) were excluded. Women who experienced 
intrauterine fetal death (IUFD) before the decision for intervention were 
excluded from the analysis of perinatal outcomes. Ethical approval for the 
present study was obtained from the Mulago National Referral Hospital 
Research and Ethics Committee (MREC 489) and the Uganda National 
Council for Science and Technology, Kampala, Uganda (HS1752). 
Women provided written informed consent for their participation.
Mulago National Referral Hospital is a university teaching and gov-
ernment hospital with 2700 beds and greater than 31 000 deliveries 
recorded annually. It is the main training center for midwives, medi-
cal doctors, and obstetricians in the country. The maternity unit has 
an operating theater, which is accessible 24 hours per day. Vacuum 
extraction and cesarean delivery are performed by residents (50 trainee 
obstetricians at the center, with 5–7 on labor wards) with or without 
supervision, depending on experience, and specialist obstetricians 
(40 at the center, with 1–3 on labor wards). All doctors are trained in 
performing vacuum extraction and cesarean delivery; however, cesar-
ean delivery is undertaken more frequently than vacuum extraction 
(approximately 20 cesarean deliveries per day compared with one or 
two vacuum extractions per day at the study center). Although vacuum 
extraction is used regularly, and the hospital has a protocol with indi-
cations, the decision regarding mode of delivery depends not only on 
clinical factors but also on the doctor’s personal preference and exper-
tise, as well as the availability of theater and vacuum equipment. Many 
women undergoing cesarean delivery at Mulago National Referral 
Hospital could be eligible for vacuum extraction.7,12
The vacuum equipment used at this center comprises Kiwi vacuum 
extractors (Clinical Innovations, South Murray, Utah, USA), Bird and sil-
icone cups, with hand and foot pumps. Forceps are available, but rarely 
used, as is the case in many hospitals in LMICs.6 Spinal anesthesia during 
cesarean delivery is provided by anesthetic nurses or anesthesiologists. 
An obstetric high dependency unit is available where women are mon-
itored and given oxygen. The hospital has a general intensive care unit, 
with mechanical ventilation. There is a blood bank; however, the avail-
ability of blood for transfusion is limited. Fetal monitoring occurs using a 
Pinard fetoscope or handheld Doppler machine. The neonatology ward 
has incubators, phototherapy, and continuous positive airway pressure, 
but no mechanical ventilation. Most women come from Kampala and 
the surrounding area, although some have travelled for a day to attend 
the hospital. Delivery is free of charge, except in the private ward.
Within 24 hours of delivery, a member of the research team iden-
tified women with vacuum extraction from the delivery book. Women 
who underwent cesarean delivery were identified from the theater regis-
ter and their medical records examined to identify those who had a fully 
dilated cervix at the time of decision for cesarean delivery. Eligible women 
were asked to participate in the present study on the day after delivery.
Data were extracted from the participants’ medical records. 
Indications for SSCD and vacuum extraction were classified as “delay”, 
“fetal distress”, “maternal”, and “other” (Table S1). The women were 
also interviewed using structured questionnaires (File S1). Data were 
extracted from medical records and the admission, discharge, and 
mortality registers for neonates admitted to the neonatology unit.
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Follow- up consultations occurred at 6 weeks and 6 months after 
delivery. During these visits, women were interviewed using sem-
istructured questionnaires (File S1). Neonates were weighed and 
assessed according to the neurodevelopmental scoring chart of Van 
Wiechen.22 Verbal autopsy forms were used to determine the cause of 
any neonatal deaths that occurred after hospital discharge.23 Women 
who missed the postnatal consultations were interviewed by tele-
phone using the same questionnaire; however, questions about HIV 
status were omitted for reasons of privacy.
The primary maternal outcomes were death and a composite of 
severe maternal outcomes, defined as death, uterine rupture, hyster-
ectomy, or relaparotomy (Table S1). Secondary maternal outcomes 
were postpartum hemorrhage (PPH), infection, genital tract injury, and 
duration of hospital admission.
Primary perinatal outcomes were death after the decision for a 
second stage intervention and a composite severe perinatal outcome, 
which was defined as death, severe birth trauma, convulsions, or a 
5- minute Apgar score below four. Secondary outcomes were admis-
sion to the neonatology unit, duration of admission, and diagnosis. 
Outcomes assessed during follow- up were neonatal or infant death 
after discharge, and neurodevelopment anomalies.
Sample size calculations are shown in Table S2. Failed vacuum 
extraction with subsequent cesarean (or forceps) delivery was ana-
lyzed as part of the outcome of vacuum extraction, as this was the 
intended mode of delivery.
The data were collated using Excel 2013 (Microsoft, Redmond, WA, 
USA) and analyzed using SPSS version 24 (IBM, Armonk, NY, USA). 
Baseline characteristics were reported as numbers with percentages, 
with P values calculated using a two- sided χ2 test. However, a two- sided 
Fisher exact test was used for outcomes recorded fewer than 10 times. 
Outcome parameters were reported as numbers with percentages, P val-
ues, unadjusted (univariate) odds ratios (ORs) and, for primary outcomes, 
adjusted (multivariate) ORs with 95% confidence intervals (CIs). A mul-
tivariate logistic regression model to calculate adjusted ORs (aORs) was 
constructed to adjust for potential confounders. Factors were tested one 
by one, stratified for mode of delivery, and included in the multivariate 
model based on differences in distribution and the strongest potential 
for confounding. The number needed to treat (NNT) was calculated for 
maternal death and the composite severe maternal outcome. A P value 
of less than 0.05 was considered to be statistically significant.
3  | RESULTS
Among the 13 152 deliveries recorded during the present study 
period, 369 (2.8%) women with a term vertex singleton underwent 
(trial of) vacuum extraction and 429 (3.3%) women with a term ver-
tex singleton underwent SSCD. The inclusion process is outlined in 
Figure 1. The vacuum extraction and SSCD groups used to analyze 
maternal outcomes comprised 358 and 425 women, respectively. 
F IGURE  1 Flowchart of the study participation. Abbreviations: CD, cesarean delivery; SSCD, second stage cesarean delivery; IUFD, 
intrauterine fetal death. a Uterine rupture occurred before the decision to perform SSCD. b IUFD occurred before the decision to perform 
vacuum extraction or second-stage cesarean delivery.
Uterine rupture a (n=5)
Noncephalic (n=60)
Preterm (n=3)
Twins (n=25)
SSCD (n=557)
Cesarean delivery listed in the operating 
theater book (n=4168)
Vacuum extraction listed in the delivery book 
(n=342, of which 1 forceps delivery after 
failed vacuum extraction)
Analysis of maternal outcome (n=425)Analysis of maternal outcome (n=358) 
Analysis of perinatal outcome (n=347) 
IUFD b (n=11)
Deliveries during the present study period (n=13 152)
CD for failed vacuum extraction (n=35)
IUFD b (n=15)
Analysis of perinatal outcome (n=410) 
Women with a trial of vacuum extraction 
(n=377)
SSCD without a trial of vacuum extraction 
(n=522)
Women with term cephalic singleton (n=429)Women with term cephalic singleton (n=369) 
Twins (n=5)
Preterm (n=3)
Women not identified 
in ward (n=10)
No consent (n=1)
Women not identified 
in ward (n=3)
No consent (n=1)
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In all, 36 (9.5%) women experienced a failed vacuum extraction: 35 
of these women delivered by cesarean delivery and one by forceps. 
These 36 women were analyzed in the vacuum extraction group. 
Women who experienced IUFD before the decision to intervene were 
excluded from the analysis of perinatal outcomes. Therefore, the vac-
uum extraction and SSCD groups used to analyze perinatal outcomes 
comprised 347 and 410 women, respectively.
Baseline characteristics of the participants are shown in Table 1. 
More women in the SSCD group had a previous cesarean delivery, 
delivered a neonate weighing more than 4000 g, were in second 
stage of labor on admission, and had indication delay, fetal distress or 
impending uterine rupture. There were non- significant trends toward 
greater numbers of nulliparous women and women with HIV in the 
vacuum extraction group. Baseline data with the missing data included 
as a proportion are presented in Table S3.
Maternal outcomes at hospital discharge are shown in Table 2. In 
all, 5 (1.2%) maternal deaths during the first 6 weeks after delivery 
were found for the SSCD group; however, no maternal deaths were 
recorded in the vacuum extraction group. The difference in maternal 
mortality between the groups was not significant (P=0.066). Deaths 
in the SSCD group occurred among women who underwent the pro-
cedure for prolonged labor. The causes of death were complete spinal 
block with cardiac arrest (n=4) and complete spinal block with hypoxic 
brain damage (n=1). Contributing factors were PPH, infection, and 
aspiration pneumonia (Table S4). One woman in the vacuum extraction 
group died 5 months after delivery following an episode of fever; how-
ever, this event was unlikely to be related to mode of delivery.
As shown in Table 2, the composite severe maternal outcome was 
recorded among 3 of 358 (0.8%) women after vacuum extraction and 
18 of 425 (4.2%) women after SSCD (OR 0.19, 95% CI 0.06–0.65). The 
aOR was 0.24 (95% CI 0.07–0.84; P=0.026) (Table S5). The NNT to pre-
vent one severe maternal adverse event during or after SSCD was 28 
(95% CI 17–69) patients. The NNT to prevent one maternal death was 
85 (95% CI 45–661). Among women with relevant data available, blood 
loss of at least 500 mL was more frequent in SSCD group (P<0.001), 
blood loss of at least 1000 mL did not differ (P=0.098), and number of 
blood transfusions did not differ (P>0.99). Hospital stay was shortened 
after vacuum extraction, with a duration of 0–2 days more common in 
the vacuum extraction group (P<0.001) and a duration of longer than 
5 days more common in the SSCD group (P=0.001) (Table 2).
TABLE  1 Baseline characteristics of the participants.a,b
Characteristic Vacuum extraction (n=358) Second- stage cesarean delivery (n=425) P valuec
Maternal
Nulliparous 201/352 (57.1) 215/425 (50.6) 0.070
Age <20 y 84/353 (23.8) 91/424 (21.5) 0.438
Education ≤6 y 86/349 (24.6) 105/413 (25.4) 0.804
Previous cesarean delivery 38/351 (10.8) 102/425 (24.0) <0.001
HIV- positive status 36/296 (12.2) 30/364 (8.2) 0.095
Eclampsia 2/358 (0.6) 4/425 (0.9) 0.693
Neonatal
Intrauterine fetal deathd 11/358 (3.1) 15/425 (3.5) 0.722
Male sex 198/354 (55.9) 232/422 (55.0) 0.790
Delivery weight >4000 g 10/353 (2.8) 32/420 (7.6) 0.003
Labor and delivery factorse
Referral 153/349 (43.8) 208/423 (49.2) 0.139
In second stage of labor at hospital admission 138/349 (39.5) 203/425 (47.8) 0.022
Indication
Delay 248/333 (74.5) 363/424 (85.6) <0.001
Fetal distress 34/333 (10.2) 90/424 (21.2) <0.001
Maternal 54/333 (16.2) 49/424 (11.6) 0.063
Other 14/333 (4.2) 3/424 (0.7) 0.001
Impending uterine rupture 2/358 (0.6) 12/425 (2.8) 0.017
Placental abruption 2/358 (0.6) 2/425 (0.5) >0.99
Cord prolapse 3/358 (0.8) 3/425 (0.7) >0.99
aValues are given as number/number of women or neonates with available data for this characteristic (percentage) unless indicated otherwise.
bMissing data are specified in Table S3.
cP values were calculated using a two- sided χ2 test. However, a two- sided Fisher exact test was used for outcomes recorded fewer than 10 times. The 
cut- off for statistical significance was P<0.05.
dOccurred before the decision to perform second- stage cesarean delivery or vacuum extraction.
eMore than one indication could apply.
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Maternal follow- up rates at 6 weeks after delivery were 79% for the 
vacuum extraction group and 87% for the SSCD group (Fig. S1). Maternal 
infection and urogenital tract injuries that had occurred after vacuum 
extraction or SSCD and were reported at the 6 week follow-up consul-
tation are shown in Table 3. Infection had occurred among 10 (3.5%) 
women after vacuum extraction and 58 (15.9%) women after SSCD; 
the OR was 0.19 (95% CI 0.10–0.39; P<0.001). An obstetric fistula after 
failed vacuum extraction and subsequent cesarean delivery was recorded 
in 1 (0.4%) woman, and 4 women (1.1%) developed an obstetric fistula 
after SSCD (P=0.393). Urine incontinence was present in 6 women (2.1%) 
after vacuum extraction and in 9 women (2.5%) after SSCD (P=0.766).
As shown in Table 4, perinatal death was recorded in similar num-
bers of neonates in the vacuum extraction and SSCD groups (OR 0.74, 
95% CI 0.45–1.21; P=0.227); the aOR was 0.83 (95% CI 0.49–1.41; 
P=0.483) (Table S6). The composite severe perinatal outcome was also 
recorded at a similar rate in both groups (OR 0.96, 95% CI 0.63–1.47; 
P=0.857); the aOR was 1.04 (95% CI 0.66–1.66; P=0.854) (Table S7). 
Neonates were admitted to the neonatology unit more frequently fol-
lowing vacuum extraction than following SSCD (P=0.048) (Table 4). 
Admissions to the neonatology unit for longer than 2 days were 
comparable between the groups (P=0.737), indicating that the “extra 
admissions” after vacuum extraction were usually for a short period. 
Severe neonatal trauma was infrequent and occurred after six vacuum 
extractions versus three in SSCD (Table S8).
At 6- month follow- up, two (out of six) infants that had experi-
enced severe trauma after vacuum extraction had died, whereas four 
had developed normally (three according to examination during fol-
low- up visit using the scoring chart of Van Wiechen22) and one (who 
had dislocation of a leg) according to maternal report by telephone 
(Table S8). After SSCD, one (out of three) infant had died, one was lost 
to follow- up, and one showed developmental anomalies suggestive of 
brain damage (Table S8). Among the 74 perinatal deaths that occurred 
during admission (regardless of mode of delivery), 68 (91.9%) had birth 
asphyxia as the only identifiable cause of death (Table S9).
DDI data are outlined in Table 4. The median DDIs were 25 min-
utes for successful vacuum extraction; 97 minutes for failed vacuum 
extraction; and 144 minutes for SSCD. During the DDI, 3 (0.9%) fetal 
deaths occurred in the vacuum extraction group compared with 18 
(4.4%) in the SSCD group (OR 0.19, 95% CI 0.06–0.65; P=0.003). The 
aOR was 0.24 (95% CI 0.07–0.84; P=0.025) (Table S10).
TABLE  2 Maternal outcome at hospital discharge.a,b
Outcome
Vacuum extraction  
(n=358)
Second- stage cesarean 
delivery (n=425) OR (95% CI)c P valued
Maternal mortality 0 5 (1.2) NA 0.066
Severe maternal outcomee 3 (0.8) 18 (4.2) 0.19 (0.06–0.65) 0.003
Postpartum hemorrhage
Blood loss documented 307 (85.8) 350 (82.4) 1.29 (0.88–1.90) 0.197
Volume, mL
≥500 22/307 (7.2) 210/350 (60.0) 0.05 (0.03–0.08) <0.001
≥1000 3/307 (1.0) 10/350 (2.9) 0.34 (0.09–1.23) 0.098
Blood transfusion 3 (0.8) 4 (0.9) 0.89 (0.20–4.00) >0.99
Urogenital tract injury
Uterine rupture 2 (0.6) 8 (1.9) 0.29 (0.06–1.39) 0.100
Cervical tear 3 (0.8) 0 NA 0.095
Anal sphincter rupture 3 (0.8) 0 NA 0.095
Operation during hospital admission
Hysterectomy 1 (0.3) 4 (0.9) 0.30 (0.03–2.65) 0.383
Relaparotomyf 3 (0.8) 5 (1.2) 0.71 (0.17–2.99) 0.733
Hospital stay
Date of discharge documented 231 (64.5) 289 (68.0) 0.86 (0.64–1.15) 0.305
Length of stay, d
0–2 186/231 (80.5) 60/289 (20.8) 15.78 (10.24–24.31) <0.001
>5 12/231 (5.2) 38/289 (13.1) 0.36 (0.18–0.71) 0.002
Abbreviations: OR, odds ratio; CI, confidence interval; NA, not applicable.
aValues are given as number (percentage) unless indicated otherwise.
bMore than one adverse event could apply.
cORs and 95% CIs were calculated using univariate logistic regression analysis. Calculations of adjusted OR’s are shown in Table S5.
dP values were calculated using a two- sided χ2 test. However, a two- sided Fisher exact test was used for outcomes recorded fewer than 10 times. The 
cut- off for statistical significance was P<0.05.
eDeath, uterine rupture, hysterectomy, or relaparotomy.
fRelaparotomy after cesarean delivery or laparotomy after vacuum extraction.
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As shown in Figure S2, neonatal and infant follow- up rates were 
82% after vacuum extraction and 89% after SSCD. The rates at 
6 months were 79% and 83%, respectively.
After 6 months, 39 of 347 (11.2%) infants in the vacuum extraction 
group and 51 of 410 (12.4%) infants in the SSCD group had died; the 
OR was 0.89 (95% CI 0.57–1.39). However, some deaths could have 
been missed owing to loss of participants to follow- up. At 6- month 
follow- up, 131 infants in the vacuum extraction group and 107 infants 
in the SSCD were examined. In each group, one infant showed devel-
opmental anomalies suggestive of brain damage. Tests for HIV infec-
tion were recorded for 14 infants among the mothers with HIV who 
had attended the 6- month follow- up consultation; 10 in the vacuum 
extraction group and four in the SSCD group. All of these infants had 
negative HIV polymerase chain reaction test results at 6 weeks after 
delivery. The mothers of these infants had received antiretroviral ther-
apy during pregnancy.
Of the 140 study participants with one or more previous cesar-
ean deliveries, 65 (46.4%) were admitted to hospital during the second 
stage of labor. Of the 33 women with two or more previous cesarean 
deliveries, 23 (69.7%) were in the second stage of labor on admission; 
of these patients, two delivered by vacuum extraction and 21 under-
went SSCD. Of the 358 women who underwent vacuum extraction, 79 
(22.1%) had been expected to undergo SSCD; however, while waiting 
for theater space, vacuum extraction was performed instead. Among 
these 79 women, 1 (1.3%) experienced a severe maternal outcome 
(uterine rupture) and vacuum extraction was successful among 73 
(92.4%). Among 76 viable fetuses, 6 (7.9%) neonatal deaths occurred; 
no other severe perinatal complications were recorded among these 
participants. Maternal and perinatal outcomes among women who had 
undergone vacuum extraction after initially being scheduled for SSCD 
were comparable to those of the vacuum extraction group as a whole.
4  | DISCUSSION
The present study found fewer maternal complications after vacuum 
extraction than after SSCD, whereas perinatal outcomes were compa-
rable for the two groups. Severe neonatal trauma and brain damage 
were infrequent regardless of the mode of delivery. The risk of severe 
maternal complications—including death—during or after SSCD was 
one per 24 women.
The present findings from Uganda were consistent with those 
from high- income countries, indicating that vacuum extraction is a 
safe intervention and that SSCD carries an increased risk of maternal 
adverse events.3,5,12 Indeed, one study found maternal and neonatal 
mortality to be higher following cesarean delivery compared with vag-
inal, especially in African countries.24
The present study found no maternal deaths after vacuum 
extraction but five after SSCD. Although this observation did not 
reach statistical significance, it is suggested here that this is highly rel-
evant and probably not random. Anesthetic adverse events played an 
important role in this study (Table S4). All five women who died were 
TABLE  3 Maternal infection and urogenital tract injury at 6 wk of follow- up.a,b
Outcome
Vacuum extraction  
(n=284)
Second- stage cesarean  
delivery (n=365) OR (95% CI)c P valued
Infection
Total infections 10 (3.5) 58 (15.9) 0.19 (0.10–0.39) <0.001
Wound infectione 6 (2.1) 43 (11.8) 0.16 (0.07–0.39) <0.001
Sepsis and/or fever 5 (1.8) 21 (5.8) 0.29 (0.11–0.79) 0.010
Wound dehiscence or burst abdomen 2 (0.7) 8 (2.2) 0.32 (0.07–1.50) 0.127
Peritonitis or pelvic abscess 0 2 (0.5) NA 0.507
Urogenital tract injury
Obstetric fistulaf 1 (0.4) 4 (1.1) 0.32 (0.04–2.87) 0.393
Urine incontinence ≥6 wk 6 (2.1) 9 (2.5) 0.85 (0.30–2.43) 0.766
Fecal incontinence ≥6 wk 0 0 NA
Surgical interventiong
Obstetric fistula repair 1 (0.4) 4 (1.1) 0.32 (0.04–2.87) 0.393
Wound closure and/or drainage of pus 1 (0.4) 5 (1.4) 0.23 (0.03–2.00) 0.239
Laparotomy for pelvic abscess 0 1 (0.3) NA >0.99
Abbreviations: OR, odds ratio; CI, confidence interval; NA, not applicable.
aValues are given as number (percentage) unless indicated otherwise.
bMore than one adverse event could apply.
cORs and 95% CIs were calculated using univariate logistic regression analysis.
dP values calculated using a two- sided χ2 test. However, a two- sided Fisher exact test was used for outcomes recorded fewer than 10 times. The cut- off 
for statistical significance was P<0.05.
eInfection of the operation wound or perineum.
fObstetric fistula in the vacuum extraction group occurred following failed vacuum extraction and subsequent cesarean delivery.
gThese operations were performed on re- admission and are not included in Table 2.
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suspected to have had hypoxia following complete spinal block, some 
in addition to other adverse events (sepsis, PPH). These maternal 
deaths following complete spinal block show that improvement in the 
quality of anesthetic care is needed and that preventing unnecessary 
surgery is of the utmost importance.14
A strength of the present study was the setting; namely, the largest 
teaching hospital in Uganda, which records a high number of deliveries 
each year. Almost all eligible women were included, thereby minimizing 
selection bias. The present findings could be generalized to many hospi-
tals among LMICs, where access to safe surgery, anesthesia, and blood 
for transfusion is limited, and infection rates are high. The duration of 
follow- up added value to the present study by showing that almost all 
infants that attended the 6- months postnatal consultation had devel-
oped normally, including those with initial severe neonatal trauma.
A potential limitation of the present study was the observational 
design; however, a randomized trial would have been unethical owing 
to the exposure of many more participants to the increased risks of 
surgery and a lengthened waiting time, with increased risk of birth 
asphyxia and adverse maternal outcomes.6,24 Consequently, the cur-
rent results must be interpreted with caution. For example, the group 
TABLE  4 Perinatal outcomes.a,b
Outcome
Vacuum extraction  
(n=347)
Second- stage cesarean  
delivery (n=410) OR (95% CI)c P valued
Perinatal death 29 (8.4) 45 (11.0) 0.74 (0.45–1.21) 0.227
Severe perinatal outcomee 45 (13.0) 55 (13.4) 0.96 (0.63–1.47) 0.857
Timing of death
During DDI 3 (0.9) 18 (4.4) 0.19 (0.06–0.65) 0.003
Early neonatal periodf 26 (7.5) 27 (6.6) 1.15 (0.66–2.01) 0.626
DDI
Documented 225 (64.8) 364 (88.8) 0.23 (0.16–0.34) <0.001
Duration >60 min 66/225 (29.3) 298/364 (81.9) 0.09 (0.06–0.14) <0.001
Adverse events among surviving neonatesg 318 365
Birth asphyxia 41 (12.9) 40 (11.0) 1.20 (0.76–1.91) 0.435
Convulsions 11 (3.5) 7 (1.9) 1.83 (0.70–4.79) 0.210
Sepsis and/or fever 14 (4.4) 14 (3.8) 1.16 (0.54–2.46) 0.709
Jaundice 8 (2.5) 7 (1.9) 1.32 (0.47–3.68) 0.595
Feeding difficulties 4 (1.3) 2 (0.5) 2.31 (0.42–12.71) 0.425
Breathing difficulties 17 (5.3) 15 (4.1) 1.32 (0.65–2.68) 0.446
Continuous positive airway pressure administered 10 (3.1) 5 (1.4) 2.34 (0.79–6.91) 0.114
Severe traumah 4 (1.3) 2 (0.5) 2.31 (0.42–12.71) 0.425
Minor traumai 5 (1.6) 2 (0.5) 2.90 (0.56–15.05) 0.260
All trauma 9 (2.8) 4 (1.1) 2.63 (0.80–8.62) 0.098
5- min Apgar score among surviving neonates
<7 18/314 (5.7) 19/362 (5.2) 1.10 (0.57–2.13) 0.783
<4 2/314 (0.6) 3/362 (0.8) 0.77 (0.13–4.62) >0.99
Admission to neonatology unit among surviving neonates
Total no. of admissions 80 (25.2) 69 (18.9) 1.44 (1.00–2.08) 0.048
Duration of admission, d
>2 42/315 (13.3) 45/361 (12.5) 1.08 (0.69–1.70) 0.737
>7 11/315 (3.5) 12/361 (3.3) 1.05 (0.46–2.42) 0.904
Abbreviations: OR, odds ratio; CI, confidence interval; DDI, decision- to- delivery interval.
aValues are given as number (percentage) unless indicated otherwise.
bOutcomes assessed at hospital discharge or 1 wk after admission to the neonatology unit.
cORs and 95% CIs were calculated using univariate logistic regression analysis. Calculations of adjusted ORs are presented in Tables S6, S7, and S10.
dP values were calculated using a two- sided χ2 test. However, a two- sided Fisher exact test was used for outcomes recorded fewer than 10 times. The 
cut- off for statistical significance was P<0.05.
ePerinatal death, severe trauma, 5- min Apgar score <4, or convulsions.
fIn the first week after delivery.
gMore than one adverse event could apply.
hIntraventricular, intracerebral, or subgaleal hemorrhage; facial palsy; or dislocation of a leg.
iCephalohematoma or fracture of clavicula.
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of women who underwent SSCD could have had high risk profiles. 
Previous cesarean delivery, fetal weight greater than 4000 g, and 
being in the second stage of labor at hospital admission were all risk 
factors for undergoing cesarean delivery and potential risk factors for 
an unfavorable outcome. Multivariate regression models were there-
fore constructed to adjust for potential confounders. Mode of delivery 
was an independent risk factor for severe maternal outcomes and fetal 
death during DDI in all models.
The rate of women who experienced successful vacuum 
extractions while waiting for cesarean delivery was high. The rate of 
SSCD for term singletons in vertex presentation was 3.3% of all deliv-
eries at the study site and this is high compared with 1.0% in other 
studies.12,25 The vacuum extraction rate at the study site (2.8%) was 
low compared with the literature.12,25,26 Consequently, it is suggested 
that many women in the SSCD group would probably have qualified 
for vacuum extraction and that it was not only women with a higher 
risk profile who underwent cesarean delivery.
Although no data were missing for the primary outcome measures, 
incomplete documentation was a limitation of the present study. This 
deficit could have led to information bias. The fact that a considerable 
number of follow- up contacts occurred by telephone could have caused 
selection bias, in particular regarding HIV transmission status as this 
aspect was not addressed in the telephone interviews. However, the 
HIV- related outcome indicated that vacuum extraction among women 
with HIV was safe, particularly for those receiving antiretroviral ther-
apy. The present study was underpowered to draw generalizable con-
clusions about perinatal mortality owing to the sample size calculation 
being based on groups with a large difference in perinatal mortality.
In the present study, nearly half of the women with a previous 
cesarean delivery arrived at the hospital during the second stage 
of labor. This observation suggests that many women with scarred 
uteri attempted to deliver outside of hospitals. Birth asphyxia, 
rather than trauma, was the main cause of perinatal mortality. This 
finding calls for action to improve the quality of monitoring during 
labor, to prevent birth asphyxia. In all, 33 women had both IUFD 
and SSCD. The development of IUFD had been diagnosed before 
SSCD was planned among 15 women. One of these 15 women died 
and two sustained uterine rupture during DDI. A timely vacuum 
extraction or destructive operation could possibly have prevented 
these adverse outcomes.
In conclusion, it is of utmost importance that unnecessary SSCD 
is prevented whenever possible, and particularly in areas where the 
risks associated with cesarean delivery are high. Reintroduction of 
 vacuum extraction is an important strategy to limit unnecessary cesar-
ean delivery, reduce DDI, and prevent maternal and perinatal mortality 
and morbidity.
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